Group education with personal rehabilitation for idiopathic Parkinson's disease

Canadian Journal of Neurological Sciences

Volumn 36, Issue 1, 2009, Pages 51-59

  Guo, Liping ^a,b   Jiang, Yuping ^c   Yatsuya, Hiroshi ^a   Yoshida, Yoshitoku ^a   Sakamoto, Junichi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; LEVODOPA;

ADULT; AGED; ARTICLE; AWARENESS; CAREGIVER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DIETITIAN; EDUCATION PROGRAM; EVENING DOSAGE; FEMALE; GROUP THERAPY; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; HUMAN COMPUTER INTERACTION; LONG TERM CARE; MALE; MORNING DOSAGE; OCCUPATIONAL THERAPY; OUTCOME ASSESSMENT; PARKINSON DISEASE; PATIENT SATISFACTION; PATIENT SELECTION; PHYSIOTHERAPY; PILOT STUDY; PRIORITY JOURNAL; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REHABILITATION CARE; SINGLE BLIND PROCEDURE; TREATMENT RESPONSE;

EID: 61349122690     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100006314     Document Type: Article

References (27)

1. Zhang ZX, Roman GC, Hong Z, Wu CB, Qu QM, Huang JB, et al. Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai. Lancet. 2005;365(9459): 595-7.
2. Zhou ZC. On the ageing population in China. Comp Econ Soc Sys. 2007;(1):121-5. (in Chinese)
3. Cotzias GC, Van Woert MH, Schiffer LM. Aromatic amino acids and modification of parkinsonism. N Engl J Med. 1967;276(7): 374-9.
4. Martínez-Martín P. An introduction to the concept of "quality of life in Parkinson's disease". J Neurol. 1998;245 Suppl 1:S2-6.
5. Suchowersky O, Gronseth G, Perlmutter J, Reich S, Zesiewicz T, Weiner WJ. Quality Standards Subcommittee of the American Academy of Neurology. Practice Parameter: Neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review). Neurology. 2006;66(7):976-82.
6. Global Parkinson's Disease Survey Steering Committee. Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov Disord. 2002;17(1):60-7.
7. Montgomery EB Jr, Lieberman A, Singh G, Fries JF. Patient education and health promotion can be effective in Parkinson's disease: a randomized controlled trial. PROPATH Advisory Board. Am J Med. 1994;97(5):429-35.
8. Lindskov S, Westergren A, Hagell P. A controlled trial of an educational programme for people with Parkinson's disease. J Clin Nurs. 2007;16(11C):368-76.
9. Ward CD, Turpin G, Dewey ME, Fleming S, Hurwitz B, Ratib S, et al. Education for people with progressive neurological conditions can have negative effects: evidence from a randomized controlled trial. Clin Rehabil. 2004; 18(7):717-25.
10. Marchese R, Diverio M, Zucchi F, Lentino C, Abbruzzese G. The role of sensory cues in the rehabilitation of parkinsonian patients: a comparison of two physical therapy protocols. Mov Disord. 2000;15(5):879-83.
11. Miyai I, Fujimoto Y, Yamamoto H, Ueda Y, Saito T, Nozaki S, et al. Long-term effect of body weight-supported treadmill training in Parkinson's disease: a randomized controlled trial. Arch Phys Med Rehabil. 2002;83(10):1370-3.
12. Hirsch MA, Toole T, Maitland CG, Rider RA. The effects of balance training and high-intensity resistance training on persons with idiopathic Parkinson's disease. Arch Phys Med Rehabil. 2003;84(8):1109-17.
13. Pacchetti C, Mancini F, Aglieri R, Fundarò C, Martignoni E, Nappi G. Active music therapy in Parkinson's disease: an integrative method for motor and emotional rehabilitation. Psychosom Med. 2000;62(3):386-93.
14. Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol. 1992;32 Suppl:S125-7.
15. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427-42.
16. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-98.
17. Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63-70.
18. Fydrich T, Dowdall D, Chambless DL. Reliability and validity of the Beck Anxiety Inventory. J Anxiety Disord. 1992;6(1) 55-61.
19. Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing. 1997;26(5):353-7.
20. Tsang KL, Chi I, Ho SL, Lou VW, Lee TM, Chu L. Translation and validation of the standard Chinese version of PDQ-39: a quality-of-life measure for patients with Parkinson's disease. Mov Disord. 2002;17(5):1036-40.
21. Siderowf A, McDermott M, Kieburtz K, Blindauer K, Plumb S, Shoulson I, et al. Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial. Mov Disord. 2002; 17(4):758-63.
22. Schwab RS, England AC. Projection technique for evaluation surgery in Parkinson's disease. In: Gillingham FJ, Donaldson IML, editors. Third symposium on Parkinson's disease. Edinburgh: E & S. Livingstone; 1969. p. 152-7.
23. Martin WR, Wieler M. Treatment of Parkinson's disease. Can J Neurol Sci. 2003;30 Suppl 1:S27-33.
24. Simons G, Thompson SB, Smith Pasqualini MC. An innovative education programme for people with Parkinson's disease and their carers. Parkinsonism Relat Disord. 2006,12(8):478-85.
25. Macht M, Gerlich C, Ellgring H, Schradi M, Rusiñol AB, Crespo M, et al. Patient education in Parkinson's disease: formative evaluation of a standardized programme in seven European countries. Patient Educ Couns. 2007;65(2):245-52.
26. Shimbo T, Goto M, Morimoto T, Hira K, Takemura M, Matsui K, et al. Association between patient education and health-related quality of life in patients with Parkinson's disease. Qual Life Res. 2004;13(1):81-9.
27. Cheng EM, Swarztrauber K, Siderowf AD, Eisa MS, Lee M, Vassar S, et al. Association of specialist involvement and quality of care for Parkinson's disease. Mov Disord. 2007;22(4):515-22.